Published in AJR Am J Roentgenol on March 01, 1990
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int (2010) 5.02
Diagnosis of hepatocellular carcinoma. HPB (Oxford) (2005) 1.43
Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol (2004) 1.31
Current role of ultrasound for the management of hepatocellular carcinoma. World J Gastroenterol (2008) 1.13
Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol (2006) 1.04
Contrast-enhanced multiphase dynamic ultrasonography for the characterization of liver tumors. J Med Ultrason (2001) (2005) 0.96
Use of second generation contrast-enhanced ultrasound in the assessment of focal liver lesions. World J Gastroenterol (2007) 0.94
Colour Doppler sonography of hepatic haemangiomas with arterioportal shunts. Br J Radiol (2011) 0.91
Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CT and conventional color/power Doppler ultrasound. Eur Radiol (2003) 0.86
US power Doppler of hepatic angiomyolipoma with low fat content. Eur Radiol (2000) 0.85
Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging. J Med Ultrason (2001) (2003) 0.84
Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT. Br J Radiol (2010) 0.81
Quantitative dynamic contrast-enhanced sonography of hepatic tumors. Eur Radiol (2004) 0.80
Imaging hemodynamics. Cancer Metastasis Rev (2008) 0.79
Clinical utility of doppler ultrasonography in evaluation of early therapeutic efficacy after transcatheter arterial embolization in patients with hepatocellular carcinoma. J Med Ultrason (2001) (2002) 0.78
Differentiation between malignant and benign nodules in the liver: use of contrast C3-MODE technology. World J Gastroenterol (2005) 0.78
Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma. Int J Clin Oncol (2006) 0.78
Three-dimensional imaging for hepatobiliary and pancreatic diseases: Emphasis on clinical utility. Indian J Radiol Imaging (2009) 0.77
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int (2017) 0.77
Characterization of focal liver lesions with contrast-enhanced ultrasound. Eur Radiol (2003) 0.76
Contrast advanced dynamic flow imaging and contrast pulse subtraction imaging: Preliminary results in hepatic tumors. J Med Ultrason (2001) (2002) 0.76
Resistance index in differential diagnosis of liver lesions by color doppler ultrasonography. World J Gastroenterol (2004) 0.75
Value of new contrast harmonic technique for detecting tumor vascularity in hepatocellular carcinoma: Preliminary results. J Med Ultrason (2001) (2003) 0.75
B-flow imaging of vascular structure for the diagnosis of liver tumor. J Med Ultrason (2001) (2013) 0.75
Assessment of image quality of contrast-enhanced power doppler imaging in hepatocellular carcinoma with the personal ultrasound imager: Comparison with the conventional machine. J Med Ultrason (2001) (2003) 0.75
Multiple anechoic hepatic nodules in a patient with malignant lymphoma: report of a case with an emphasis on B-mode sonograms. J Med Ultrason (2001) (2008) 0.75
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
Functional annotation of a full-length mouse cDNA collection. Nature (2001) 23.61
Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity (1998) 18.12
Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther (2000) 12.54
PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell (1999) 7.56
Essential role of Stat6 in IL-4 signalling. Nature (1996) 6.56
Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med (1993) 5.32
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet (2000) 5.26
Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science (1997) 5.16
Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group. Nature (1988) 5.09
The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest (2001) 4.93
Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity (1998) 4.70
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature (1990) 4.64
Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol (2000) 4.10
Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med (2000) 3.57
IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol (1998) 3.56
Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium. Proc Natl Acad Sci U S A (1998) 3.54
Applications of retrovirus-mediated expression cloning. Exp Hematol (1996) 3.40
1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci U S A (1994) 3.37
Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A (1997) 3.37
Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci U S A (1990) 3.36
Cytokine receptors and signal transduction. Annu Rev Immunol (1992) 3.27
Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol Cell Biol (1998) 3.23
Purification of a calmodulin-binding protein from chicken gizzard that interacts with F-actin. Proc Natl Acad Sci U S A (1981) 3.14
STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J (1999) 3.14
A rhodopsin is the functional photoreceptor for phototaxis in the unicellular eukaryote Chlamydomonas. Nature (1984) 3.09
Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. J Biol Chem (1999) 2.99
Kabuki make-up (Niikawa-Kuroki) syndrome: a study of 62 patients. Am J Med Genet (1988) 2.94
The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci (2000) 2.92
A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. Invest Ophthalmol Vis Sci (1999) 2.89
Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation (1999) 2.77
Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines. Oncogene (2000) 2.73
Identification of retinal isomers isolated from bacteriorhodopsin. Biochemistry (1977) 2.67
Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. J Virol (1990) 2.58
DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity (1996) 2.56
Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med (1999) 2.51
On the structural diversity of fern antheridiogens. Naturwissenschaften (1972) 2.47
Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol (1998) 2.42
Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Mol Cell (2000) 2.41
TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet (2001) 2.37
IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci U S A (1999) 2.35
Benzo(a)pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. Science (1976) 2.34
Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol Cell Biol (1998) 2.32
The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function. J Exp Med (1999) 2.32
Isolation and indentification on meiosis inducing substance in starfish Asterias amurensis. Nature (1969) 2.29
The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem (2001) 2.29
Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nat Genet (1999) 2.28
The role of hydrated silica, titania, and alumina in inducing apatite on implants. J Biomed Mater Res (1994) 2.25
The biosynthesis of A2E, a fluorophore of aging retina, involves the formation of the precursor, A2-PE, in the photoreceptor outer segment membrane. J Biol Chem (2000) 2.25
Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol (1998) 2.23
Structure of the fluorescent Y base from yeast phenylalanine transfer ribonucleic acid. J Am Chem Soc (1970) 2.21
Time to recurrence after recovery from major depressive episodes and its predictors. Psychol Med (2003) 2.14
Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J (1992) 2.11
Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. Circulation (2000) 2.11
Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J (1999) 2.10
3-(3-amino-3-carboxy-n-propyl)uridine. The structure of the nucleoside in Escherichia coli transfer ribonucleic acid that reacts with phenoxyacetoxysuccinimide. Biochemistry (1974) 2.06
Stent placement for recurrent vasospastic angina resistant to medical treatment. Cathet Cardiovasc Diagn (1997) 2.05
Transforming growth factor-beta regulates production of proteoglycans by mesangial cells. Kidney Int (1990) 2.04
Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proc Natl Acad Sci U S A (1999) 2.04
Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int (2000) 2.03
Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J (1996) 2.02
Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am J Respir Cell Mol Biol (1997) 2.02
MgcRacGAP is involved in cytokinesis through associating with mitotic spindle and midbody. J Biol Chem (2000) 1.99
Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production. J Exp Med (1998) 1.99
Binding site of cerulenin in fatty acid synthetase. J Biochem (1989) 1.98
CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J Biol Chem (2000) 1.97
Essential role of the posterior morphogen nanos for germline development in Drosophila. Nature (1996) 1.96
Assessment of vasoactive agents and vascular aging by the second derivative of photoplethysmogram waveform. Hypertension (1998) 1.96
Catalytic functionalization of arenes and alkanes via C-H bond activation. Acc Chem Res (2001) 1.95
IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner. Gut (2000) 1.95
Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc Natl Acad Sci U S A (1997) 1.92
Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science (1987) 1.91
Differential isolation of microvillous and basolateral plasma membranes from intestinal mucosa: mutually exclusive distribution of digestive enzymes and ouabain-sensitive ATPase. Biochim Biophys Acta (1972) 1.86
Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs. Circulation (1993) 1.86
IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat Immunol (2000) 1.86
IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol (1996) 1.85
The rate with which spontaneous mutation alters the electrophoretic mobility of polypeptides. Proc Natl Acad Sci U S A (1986) 1.85
Cloning and expression of a gene encoding an interleukin 3 receptor-like protein: identification of another member of the cytokine receptor gene family. Proc Natl Acad Sci U S A (1990) 1.85
Strain on intervertebral discs after anterior cervical decompression and fusion. Spine (Phila Pa 1976) (1999) 1.84
Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by(13)N-ammonia positron emission tomography. Eur Heart J (2001) 1.83
Chromophore/protein interaction in bacterial sensory rhodopsin and bacteriorhodopsin. Biophys J (1986) 1.83
Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J Immunol (2001) 1.82
Search for mutations affecting protein structure in children of atomic bomb survivors: preliminary report. Proc Natl Acad Sci U S A (1980) 1.80
Prognostic factors and a scoring system for patients with skeletal metastasis. J Bone Joint Surg Br (2005) 1.80
Retinal analog restoration of photophobic responses in a blind Chlamydomonas reinhardtii mutant. Evidence for an archaebacterial like chromophore in a eukaryotic rhodopsin. Biophys J (1991) 1.78
Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL). Hum Genet (1999) 1.77
Photoisomerization of retinal at 13-ene is important for phototaxis of Chlamydomonas reinhardtii: simultaneous measurements of phototactic and photophobic responses. Biochem Biophys Res Commun (1991) 1.77
Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line. Biochem Biophys Res Commun (1999) 1.75
Search for mutations altering protein charge and/or function in children of atomic bomb survivors: final report. Am J Hum Genet (1988) 1.74
Solid and papillary neoplasm arising from an ectopic pancreas in the mesocolon. Am J Gastroenterol (1990) 1.74
Interleukin 2 induces antigen-reactive T cell lines to secrete BCGF-I. J Exp Med (1983) 1.71
Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J Immunol (1999) 1.69
Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublines. Cancer Res (1986) 1.68
Movement of retinal along the visual transduction path. Science (2000) 1.68
Autoradiographic studies on histogenesis of brain macrophages in the mouse. J Neuropathol Exp Neurol (1972) 1.68
Structures of benzo(a)pyrene--nucleic acid adducts formed in human and bovine bronchial explants. Nature (1977) 1.68
Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity (1999) 1.67
The chemistry of brevetoxins: a review. Toxicon (1985) 1.67
Cross-sectional area of the stenotic lumbar dural tube measured from the transverse views of magnetic resonance imaging. J Spinal Disord (1994) 1.65